Genotoxicity potential of 8-Cl-cyclic adenosine monophosphate assessed with cytogenetic tests in vivo

Archives of Medical Research

Volumn 35, Issue 3, 2004, Pages 209-214

  Bajic, Vladan ^a   Stanimirovic, Zoran ^b   Stevanovic, Jevrosima ^b  

^a GALENIKA Ad ^*  (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Antitumor agent 8 Cl cAMP; Genotoxicity; Micronucleus test; Numerical and structural chromosomal aberrations

Indexed keywords

8 CHLOROADENOSINE 3',5' CYCLIC MONOPHOSPHATE; CLASTOGEN; CYCLIC AMP; CYCLOPHOSPHAMIDE; MUTAGENIC AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANEUPLOIDY; ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CANCER CELL CULTURE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DETERMINATION; DNA STRUCTURE; EXPERIMENTAL TEST; GENE TRANSLOCATION; GENOTOXICITY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; MICROMORPHOLOGY; MOUSE; NONHUMAN; POLYPLOIDY; QUANTITATIVE ANALYSIS;

EID: 2442421673     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2004.01.004     Document Type: Article

References (52)

1. Cho-Chung Y.S., Clair T., Tagliaferri P., Ally S., Katsaros D., Tortora G., Neckers L., Avery T.L., Crabtree G.W., Robins R.K. Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation. Cancer Invest. 7:(2):1989;161-177
2. Cho-Chung Y.S. Role of cyclic AMP receptor proteins in growth, differentiation and suppression of malignancy: new approach to therapy. Cancer Res. 50:1990;7093-7100
3. Ciardiello F., Tortora G., Kim N., Clair T., Ally S., Salomon D.S., Cho-Chung Y.S. 8-chloro-cAMP inhibits transforming growth factor α transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation. J Biol Chem. 265:1990;1016-1020
4. Rohlff C., Clair T., Cho-Chung Y.S. 8-Cl-cAMP induces truncation and down regulation RI-α subunit of cAMP-dependent protein kinase leading to type IIβ holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J Biol Chem. 268:1993;5774-5782
5. Gandhi V., Ayres M., Halgren R.G., Krett N.L., Newman R.A., Rosen S.T. 8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells. Cancer Res. 61:2001;5474-5479
6. Lamb D., Steinberg R.A. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression. J Cell Physiol. 192:2002;216-224
7. Taylor C.W., Yeoman L.C. Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine. Anticancer Drugs. 3:1992;485-491
8. Halgren R.G., Traynor A.E., Pillay S., Zell J.L., Heller K.F., Krett N.L., Rosen S.T. 8Cl-cAMP cytotoxicity in both steroid sensitive and insensitive multiple myeloma cell lines is mediated by 8Cl-adenosine. Blood. 92:(8):1998;2893-2898
9. Van Lookeren Campagne M.M., Villalba Díaz F., Jastorff B., Kessin R.H. 8-Chloro-adenosine 3′, 5′-monophosphate inhibits the growth of Chinese hamster ovary and Molt-4 cells through its adenosine metabolite. Cancer Res. 51:1991;1600-1605
10. Langeveld C.H., Jongenelen A.M., Heimans J.J., Stoof J.C. Growth inhibition of human glioma cells induced by 8-chloroadenosine, an active metabolite of 8-chloro cyclic adenosine 3′, 5′-monophosphate. Cancer Res. 51:1991;6207-6208
11. Lange-Carter C.A., Vuillequez J.J., Malkinson A.M. 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP independent mechanism. Cancer Res. 53:1993;393-400
12. Langeveld C.H., Jongenelen A.M., Theeuwes J.W.M., Baak J.P.A., Heimans J.J., Stoof J.C., Peters G.J. The antiproliferative effect of 8-chloroadenosine, an active metabolite of 8-chloro-cyclic adenosine monophosphate, and disturbances in nucleic acid synthesis and cell cycle kinetics. Biochem Pharmacol. 53:1997;141-148
13. Dixit R., Stoltz M., Douglas R., Reddy R.V. Pharmacokinetics and dose range finding of 8-chloroadenosine 3′, 5′-cyclic monophosphate in Beagle dogs. Govt Reports Announce Index. 25:1993;72-81. (Issue 11)
14. Tortora G., Tagliaferri P., Bianco C., Gurrassi R., Pepe S., Miki K., Bianco R. Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients. Clin Cancer Res. I:1995;377-386
15. Schmid W. The micronucleus test. Mutat Res. 31:1975;9-15
16. Hsu T.C., Patton G.L. Bone marrow preparations for chromosome studies. Benirische K. Comparative mammalian cytogenetics. 1969;454-460 Springer-Verlag, Berlin
17. Zimonjic D.B., Savkovic N., Andjelkovic M. Genotoxic agents: the effects, principles and methodology of detection. 1990;Naucna Knjiga Beograd. pp.1-395
18. Bajic V. Investigation of genotoxic potential of 8-Cl-cAMP on in vivo model of BALB/c mouse. M.Sc. thesis. 1998;Faculty of Veterinary Medicine, University of Belgrade, Belgrade, Yugoslavia
19. Aardema M.J. Current topics in in vivo cytogenetics. Environ Mol Mutagen. 25:1995;300-301
20. Anderson D., Bishop J.B., Garner R.C., Selby P.B. Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat Res. 330:1995;115-118
21. Tunka B.T., Egeli U. Cytogenetic findings on shoe workers exposed long-term to benzene. Environ Health Perspect. 104:(6):1996;1313-1317
22. Meng Z., Zhang B. Chromosomal aberrations and micronuclei in lymphocytes of workers at a phosphate fertilizer factory. Mutat Res. 393:1997;283-288
23. Pedersen-Bjergaard J., Hansen V.L., Struck J., Hanse M., Nissen N.I. Carcinoma of urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med. 381:1988;1028-1032
24. Pedersen-Bjergaard J., Philip P. Therapy related malignancies: a review. Eur J Haematol. 42:1989;39-47
25. Bajic V. The importance of premature centromere separation as a parameter of genome instability in assessing genotoxic effects of cytostatics. Ph.D. thesis. 2002;Faculty of Veterinary Medicine, University of Belgrade, Belgrade, Yugoslavia
26. Spremo-Potparevic B., Bajic V. Premature centromere separation: a manifestation of genome instability? Balkan J Med Genet. 3:(3):2000;19-22
27. Rusov C., Zivkovic R., Soldatovic B., Jojic-Malicevic L.J., Stanimirovic Z. A study of selenium genotoxicity in the micronucleus test on mice. Acta Vet (Beograd). 45:(2-3):1996;161-166
28. Cummings J., Langdon S.P., Ritchie A.A., Burns D.J., MacKay J., Stockman P., Leonard R.C., Miller W.R. Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3′, 5′-monophosphate in breast cancer patients and xenograft bearing mice. Ann Oncol. 7:1996;291-296
29. Srivastava R.K., Srivastava A.R., Korsmeyer S.J., Nesterova M., Cho-Chung Y.S., Longo D.L. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol. 6:(18):1998;3509-3517
30. Legator S., Au W. Application of integrated genetic monitoring: the optimal approach for detecting environmental carcinogens. Environ Health Persp. 102:1994;125-132
31. ® on the chromosomes of mammals in vivo. Acta Vet (Belgrade). 44:(5-6):1994;345-350
32. Stanimirovic Z. Comparative analyses of natural and induced polymorphism of chromosomes in the species Mus musculus, Linne (1758). Ph.D. thesis. 1995;Faculty of Biology, University of Belgrade, Belgrade, Yugoslavia
33. Stanimirovic Z., Vucinic M., Soldatovic B., Markovic B. Genotoxicity and potential chemosterilant effects of Rosol. Acta Vet (Belgrade). 47:(4):1997;237-246
34. Stanimirovic Z., Vucinic M., Soldatovic B. Cytogenetic changes in bone marrow cells of Wistar rats induced by levamisole hydrochloride. Acta Vet (Belgrade). 48:(4):1998;255-262
35. Stanimirovic Z., Todorovic D., Stevanovic J., Mladenovic M., Jankovic L.J., Corcevic M. Influence of cymiazole hydrochloride on mitotic and proliferative activities of cultured human lymphocytes. Acta Vet (Belgrade). 53:(1):2003;47-55
36. Markovic B. Genotoxic effect of rodenticide Rosola in laboratory mouse BALB/c strain. M.Sc. thesis. 1996;Faculty of Biology, University of Belgrade, Belgrade, Yugoslavia
37. Markovic B. Genotoxic effects of antibiotic preparations Carbadox, Gastrogal 10 and Tiamulin S. Ph.D. thesis. 1999;Faculty of Biology, University of Belgrade, Belgrade, Yugoslavia
38. McDaid H.M., Johnson P.G. Synergistic interaction between paclitaxel and 8-chloro-adenosine 3′, 5′-monophosphate in human ovarian carcinoma cell lines. Clin Cancer Res. 5:1999;215-220
39. Mailhes J.B., Young D., Caldito G., London S.N. Sensitivity of mouse oocytes to nicotine-induced perturbations during oocyte meiotic maturation and aneuploidy in vivo and in vitro. Mol Hum Reprod. 6:(3):2000;232-237
40. London S.N., Mailhes J.B. Tamoxifen-induced alterations in meiotic maturation and cytogenetic abnormalities in mouse oocytes and 1-cell zygotes. Zygote. 9:2001;97-104
41. Mailhes J.B., Hilliard C., Fuseler J.W., London S.N. Vanadate, an inhibitor of tyrosine phosphatases, induced premature anaphase in oocytes and aneuploidy and polyploidy in mouse bone marrow cells. Mutat Res. 538:2003;101-107
42. Juranic Z., Radulovic S., Joksimovic J., Juranic I. The mechanism of 8-Cl-cAMP action. J Exp Clin Cancer Res. 17:1998;269-275
43. Heddle J.A., Benz R.D., Countryman P.I. Measurement of chromosomal breakage in cultured cells by the micronucleus technique. Evans H.J., Lloyd D.C. Mutagen-induced chromosome damage in man. 1978;191-200 University Press Edinburgh, Edinburgh, UK
44. Heddle J.A. Micronuclei in vivo. Mendelsohn M.L., Albertini R.J. Mutation and the environment, B. 1990;185-194 Wiley-Liss, New York
45. Mailhes J.B., Young D., London S.N. Cytogenetic effects of caffeine during in vivo mouse oocyte maturation. Mutagenesis. 11:(4):1996;395-399
46. Limoli C.L., Kaplan M.I., Phillips J.P., Adair G.M., Morgan W.F. Differential induction of chromosomal instability by DNA strand-breaking agents. Cancer Res. 57:1997;4048-4056
47. Corcoran G.B., Fix L., Jones D.P. Apoptosis: molecular control point in toxicity. Toxicol Appl Pharmacol. 128:1994;169-181
48. Boe R., Gjertsen B.T., Doskeland S., Vintermyr O.K. 8-Chloro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) cell line. Br J Cancer. 72:1995;1151-1159
49. Brown J.M., Wouters G.B. Apoptosis, p53 and tumor cell sensitivity to antitumor agents. Cancer Res. 59:1999;1391-1399
50. Srivastava R.K., Srivastava A.R., Cho-Chung Y.S., Longo D.L. Synergistic effects of retinoic acid and 8-chloro-adenosine 3′, 5′-cyclic monophosphate on the regulation of retinoic acid receptor β and apoptosis: involvement of mitochondria. Clin Cancer Res. 5:1999;1892-1904
51. Bajic V., Milicevic Z., Potparevic-Spremo B., Nedeljkovic-Kurepa A. Apoptotic versus genotoxic potential of anti-tumor agents: a concept of duality in unity. Med Hypotheses. 61:(5-6):2003;131-138
52. Cornelis H.L., Cornelis A.M., Jan J.H., Stoof J.H. Growth inhibition of human glioma cells induced by 8-chloroadenosine, an active metabolite of 8-chloro-cyclic adenosine 3:5-monophosphate. Cancer Res. 52:1992;3994-3999